Latest Biomarker Stories
LONDON, Oct. 27, 2014 /PRNewswire/ -- The immunoassay market is large and long-established, but at the same time highly competitive.
PCT-dependent Method Provides High Quality Mass Spectrometry-based Proteomic Analysis in Small Needle Biopsy Samples for the First Time, Offering Potential to Vastly Improve Drug Discovery and Design
HAMILTON, N.J., Oct.
However, Restrictions in Drug Coverage and Molecular Testing Limit Patient Access to Biomarker-Associated Agents, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct.
Variety of bio-marker collection and analysis processes to be assessed for use in printed sensor system SAN JOSE, Calif., Oct.
LONDON, Oct. 14, 2014 /PRNewswire/ -- REPORT HIGHLIGHTSThe global market for signal transduction therapies/inhibitors (JAK and PI3K) reached $173.5 million in 2012.
-New Preclinical Results Increase Mechanistic Understanding of Targeting miR-103/107 for Metabolic Disorders and miR-21 for Renal Dysfunction in Alport Syndrome Patients- LA JOLLA, Calif.,
The market is mainly driven by the increasing research funding for metabolomics from governments and private investors, growing demand for personalized medicine in the U.S.
According to new report from BCC Research, the global market for next generation (next gen) cancer diagnostics is expected to grow to $10.6 billion by 2019, with a five-year compound annual growth
- An imitative word; an onomatopoetic word.
More Images (2 images) »